Eli Lilly And Company is a pharmaceutical company focusing on the discovery, development, manufacture, and sale of products in the pharmaceutical industry. Its products are sold in approximately 135 countries and the company owns or leases facilities in the United States, Puerto Rico, and 25 other countries. The company also conducts research to find products for animal treatment and increase the efficiency of animal food production. Major products include neurosciences products such as Zyprexa, Cymbalta, Strattera, Prozac, and Symbyax, as well as endocrinology products like Humalog, Humulin, Byetta, Actos, Evista, Forteo, and Humatrope.
Founded in 1876 by Colonel Eli Lilly in Indiana, Eli Lilly and Company has grown to become an industry leader with 33,625 employees and an annual revenue of $28.5 billion. The company is currently led by CEO David A. Ricks and maintains its focus on innovation and a commitment to improve global health. Eli Lilly continues to develop new treatments for a wide range of diseases while maintaining a diverse and inclusive workforce.
